Company Strength

The Chairman of Keyuan Pharmaceutical was invited to attend the Third Global Go‑Global Summit, where they jointly explored new pathways for the pharmaceutical industry’s international expansion.

On June 28–29, the third Global Outbound Summit, hosted by the Wu Xiaobo Channel and the Chinese Business Globalization Industry Alliance, was grandly held at Resorts World Sentosa in Singapore. Centered around the theme “Born Global—Going Global for Growth,” the summit aligned with the prevailing trend of profound restructuring in global supply chains and the accelerated globalization of China’s real economy. It brought together more than 1,400 entrepreneurs from home and abroad, leading economists, representatives from top-tier investment firms, and experts from industry think tanks, creating a high‑level platform for dialogue, resource matchmaking, and knowledge sharing to support Chinese companies’ international expansion.

2026-06-29

Keyuan Group Conducts Company-Wide Training on Integrity and Compliance, Strengthening the Pharmaceutical Company’s Integrity Defense Line

To thoroughly implement the latest requirements of the Criminal Law Amendment (No. 12), effectively strengthen all employees’ awareness of integrity and compliance, prevent and mitigate internal risks of official misconduct, and safeguard the company’s high-quality development, on May 20, Keyuan Group organized a company-wide training session on corruption prevention and compliance. Led by the Human Resources Center and the Audit Center, the event adopted a hybrid online–offline format to ensure full coverage, mandatory participation, and comprehensive learning for all employees.

2026-05-20

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating intelligent manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed strong recognition of its practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.

2026-05-17